abiraterone has been researched along with lansoprazole in 1 studies
| Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (lansoprazole) | Trials (lansoprazole) | Recent Studies (post-2010) (lansoprazole) |
|---|---|---|---|---|---|
| 942 | 97 | 854 | 2,281 | 803 | 600 |
| Protein | Taxonomy | abiraterone (IC50) | lansoprazole (IC50) |
|---|---|---|---|
| phosphoethanolamine/phosphocholine phosphatase isoform 1 | Homo sapiens (human) | 0.434 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.995 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 5.3148 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.3367 | |
| WD repeat-containing protein 5 | Homo sapiens (human) | 5.9 | |
| Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 5.9 | |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | 8.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for abiraterone and lansoprazole
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |